| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.005 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |